Pantoprazole
- Level
- Commodity
- Parent
- 51171900
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51171915This classification denotes a proton pump inhibitor with the molecular formula C16H15F2N3O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier D8TST4O562, chemically known as 5-(difluoromethoxy)-2-(((3,4-dimethoxy-2-pyridyl)methyl)sulfinyl)benzimidazole but generally known as pantoprazole, which bears US NIH Compound Identifier 4679. European Medicines Agency schedules Pantoprazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09608MIG. The term PANTOPRAZOLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 4, No. 3 1990, List 30). World Health Organization schedules pantoprazole in its Anatomical Therapeutic Chemical (ATC) Classification. PANTOPRAZOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule pantoprazole under HS 29333999 and SITC 51574. As of Q4 2014, PANTOPRAZOLE remains the US FDA Preferred Term for this commodity. Pantoprazole bears US NLM identifiers UMLS ID C0081876 and NCI Concept Code C29346. SMILES: S(=O)(C1[NH]C2C(N1)CCC(OC(F)F)C2)CC1NCCC(OC)C1OC.
Same parent
Under 51171900 · 73Activities that produce or sell this
KBLI · 9Inherited from family 51170000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.